CTSK and lysosomal storage disease: The cysteine protease cathepsin K, which has long been known as a molecular marker of differentiated osteoclasts and is directly involved in the degradation of bone matrix proteins, plays a crucial role in skeletal pathologies frequently observed in MPS and in other lysosomal storage diseases (LSDs) [26,27].